Plan: OPEN | Option: Growth | Kamal Gada

14 Jan 25 | 12:00 AM

280.43 3.00 (1.08%)

  • Underperforms

    33.16%

    Return (1Y)

    underperformed BSE Healthcare TRI by -15.15%

  • Less Volatile

    0.81%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.22%

  • Inconsistent

    1/4

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • UTI-Pharma & Healthcare Fund (G) fund has been the 5th best in 5Y performance in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been given the 4th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been the 5th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year UTI-Healthcare Fund (G), has underperformed by -15.15% (CAGR difference)

33.16%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of UTI-Healthcare Fund (G) is Lower than by -0.22%

0.81%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 1 out of Last 4 Months, i.e 25% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition